Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Ontology highlight
SUBMITTER: Yang S
PROVIDER: S-EPMC7990482 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA